BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200930
DTEND;VALUE=DATE:20201001
DTSTAMP:20260515T113628
CREATED:20200715T141216Z
LAST-MODIFIED:20200715T141216Z
UID:26338-1601424000-1601510399@www.pharmajournalist.com
SUMMARY:Gene Therapy for Inherited Metabolic Disorders
DESCRIPTION:The inaugural Gene Therapy for Inherited Metabolic Disorders Summit will put the spotlight on the understanding of topics from the physiopathology of disease through to the nuances of dosing and delivery methods and designing a trial with endpoints and outcome measures that are meaningful both clinically and to patients. \n \nJoin 60+ industry leaders across the metabolic disorders space to overcome the specific delivery and drug development challenges to accelerate the development of more clinically efficacious\, durable and safe gene therapies for metabolic disorders. \nDon’t miss this opportunity to join pioneers from AstraZeneca\, Amicus Therapeutics and Rocket Pharmaceuticals on this journey to revolutionize the treatment of inherited metabolic disorders. \nTo know more about Gene Therapy for Inherited Metabolic Disorders please click here.
URL:https://www.pharmajournalist.com/event/gene-therapy-for-inherited-metabolic-disorders/
LOCATION:Online
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200930
DTEND;VALUE=DATE:20201001
DTSTAMP:20260515T113628
CREATED:20200720T141737Z
LAST-MODIFIED:20200720T141737Z
UID:26425-1601424000-1601510399@www.pharmajournalist.com
SUMMARY:Gamma Delta T Therapies Summit
DESCRIPTION:Accelerating the Development of Gamma Delta T Therapies in Oncology \nJoin us on Wednesday\, September 30\, to discuss the precise mechanisms of γδT cells\, examine donor selection for allogeneic therapies\, and deliberate the targeting of solid tumours. \nAs we virtually gather world-leading researchers at the Gamma Delta T Therapies Summit\, learn how the industry is effectively manipulating and engineering gamma delta cells with antibody and cell-based approaches for improved safety\, efficacy and manufacturability to bring to market effective Gamma Delta Therapies for patients in need. \nWith a unique opportunity to pose questions to experts and gain fresh insights on such a fast paced and growing field in a live Q&A\, this digital event is not to be missed. \nFind out more about the event and to see participation opportunities: https://ter.li/qk6gc1
URL:https://www.pharmajournalist.com/event/gamma-delta-t-therapies-summit/
LOCATION:Digital Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200930
DTEND;VALUE=DATE:20201002
DTSTAMP:20260515T113628
CREATED:20200821T150023Z
LAST-MODIFIED:20200821T150023Z
UID:26815-1601424000-1601596799@www.pharmajournalist.com
SUMMARY:5th Annual PREDiCT: 3D Oncology & Tissue Models
DESCRIPTION:The Digital 5th PREDiCT: 3D Oncology & Tissue Models Summit will return this September\, with defined tracks and a fresh speaker line-up\, bringing together preclinical scientists to discuss adoption and commercialization of 3D models as an integral part of drug development study. \nThis event is completely free for Drug Developers\, Researchers and Academics. To register your complimentary pass\, simply follow this link: www.3d-oncology-tissuemodels.com/take-part/register/. \nThis fully online meeting will feature over 30+ senior Preclinical Scientists from oncology to cardiovascular to musculoskeletal and CNS backgrounds\, to share their latest data and lessons learned from clinically translatable 3D models to disease modeling of mechanisms\, to attempting complex multi-cellular/organ systems to boost our understanding of functionality and physiological relevancy. \nEmbark on the 3D trailblazing community to boost your confidence in 3D models and accelerate bench to bedside drug development to provide a truly safe\, and effective treatment for patients! \nAccess your copy of the Full Event Guide here.
URL:https://www.pharmajournalist.com/event/5th-annual-predict-3d-oncology-tissue-models/
LOCATION:Digital Event
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR